Open Access
Hepatitis B Vaccines
Publication type: Journal Article
Publication date: 2021-09-30
scimago Q1
wos Q1
SJR: 2.038
CiteScore: 11.1
Impact factor: 4.5
ISSN: 00221899, 15376613
PubMed ID:
34590138
Infectious Diseases
Immunology and Allergy
Abstract
Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality. Affordable, safe, and effective, hepatitis B vaccines are the best tools we have to control and prevent hepatitis B. In 2019, coverage of 3 doses of the hepatitis B vaccine reached 85% worldwide compared to around 30% in 2000. The effective implementation of hepatitis B vaccination programs has resulted in a substantial decrease in the HBV carrier rate and hepatitis B-related morbidity and mortality. This article summarizes the great triumphs of the hepatitis B vaccine, the first anticancer and virus-like-particle–based vaccine. In addition, existing unresolved issues and future perspectives on hepatitis B vaccination required for global prevention of HBV infection are discussed.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Vaccines
16 publications, 8.89%
|
|
|
Viruses
8 publications, 4.44%
|
|
|
Frontiers in Immunology
6 publications, 3.33%
|
|
|
International Journal of Molecular Sciences
4 publications, 2.22%
|
|
|
Human Vaccines and Immunotherapeutics
4 publications, 2.22%
|
|
|
BMC Public Health
4 publications, 2.22%
|
|
|
Frontiers in Public Health
3 publications, 1.67%
|
|
|
Microorganisms
3 publications, 1.67%
|
|
|
Vaccine
3 publications, 1.67%
|
|
|
Expert Review of Vaccines
3 publications, 1.67%
|
|
|
Pharmaceuticals
2 publications, 1.11%
|
|
|
Scientific Reports
2 publications, 1.11%
|
|
|
BMC Gastroenterology
2 publications, 1.11%
|
|
|
Journal of Medical Virology
2 publications, 1.11%
|
|
|
IJID Regions
2 publications, 1.11%
|
|
|
Epidemiology and Vaccinal Prevention (Epidemiologiya i Vaktsinoprofilaktika)
2 publications, 1.11%
|
|
|
BMJ Open
2 publications, 1.11%
|
|
|
Frontiers in Cellular and Infection Microbiology
2 publications, 1.11%
|
|
|
BMC Nursing
2 publications, 1.11%
|
|
|
European Journal of Medical and Health Research
2 publications, 1.11%
|
|
|
Diagnostic Microbiology and Infectious Disease
2 publications, 1.11%
|
|
|
EMC - Hépatologie
2 publications, 1.11%
|
|
|
PLoS ONE
2 publications, 1.11%
|
|
|
BMC Infectious Diseases
2 publications, 1.11%
|
|
|
Diseases
1 publication, 0.56%
|
|
|
Frontiers in Genetics
1 publication, 0.56%
|
|
|
European Physical Journal Plus
1 publication, 0.56%
|
|
|
Pharmaceutical Research
1 publication, 0.56%
|
|
|
Advanced Drug Delivery Reviews
1 publication, 0.56%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Springer Nature
42 publications, 23.33%
|
|
|
MDPI
39 publications, 21.67%
|
|
|
Elsevier
31 publications, 17.22%
|
|
|
Frontiers Media S.A.
13 publications, 7.22%
|
|
|
Wiley
12 publications, 6.67%
|
|
|
Taylor & Francis
8 publications, 4.44%
|
|
|
BMJ
5 publications, 2.78%
|
|
|
Baishideng Publishing Group
4 publications, 2.22%
|
|
|
Public Library of Science (PLoS)
3 publications, 1.67%
|
|
|
American Chemical Society (ACS)
3 publications, 1.67%
|
|
|
LLC Numicom
2 publications, 1.11%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.11%
|
|
|
AMO Publisher
2 publications, 1.11%
|
|
|
IntechOpen
2 publications, 1.11%
|
|
|
SAGE
2 publications, 1.11%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 1.11%
|
|
|
Oxford University Press
1 publication, 0.56%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.56%
|
|
|
Jaypee Brothers Medical Publishing
1 publication, 0.56%
|
|
|
Apex Publishing
1 publication, 0.56%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.56%
|
|
|
Walter de Gruyter
1 publication, 0.56%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
180
Total citations:
180
Citations from 2024:
128
(71.11%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Pattyn J. et al. Hepatitis B Vaccines // Journal of Infectious Diseases. 2021. Vol. 224. No. Supplement_4. p. S343-S351.
GOST all authors (up to 50)
Copy
Pattyn J., Hendrickx G., Vorsters A., van Damme P. Hepatitis B Vaccines // Journal of Infectious Diseases. 2021. Vol. 224. No. Supplement_4. p. S343-S351.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1093/infdis/jiaa668
UR - https://doi.org/10.1093/infdis/jiaa668
TI - Hepatitis B Vaccines
T2 - Journal of Infectious Diseases
AU - Pattyn, Jade
AU - Hendrickx, Greet
AU - Vorsters, Alex
AU - van Damme, Pierre
PY - 2021
DA - 2021/09/30
PB - Oxford University Press
SP - S343-S351
IS - Supplement_4
VL - 224
PMID - 34590138
SN - 0022-1899
SN - 1537-6613
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Pattyn,
author = {Jade Pattyn and Greet Hendrickx and Alex Vorsters and Pierre van Damme},
title = {Hepatitis B Vaccines},
journal = {Journal of Infectious Diseases},
year = {2021},
volume = {224},
publisher = {Oxford University Press},
month = {sep},
url = {https://doi.org/10.1093/infdis/jiaa668},
number = {Supplement_4},
pages = {S343--S351},
doi = {10.1093/infdis/jiaa668}
}
Cite this
MLA
Copy
Pattyn, Jade, et al. “Hepatitis B Vaccines.” Journal of Infectious Diseases, vol. 224, no. Supplement_4, Sep. 2021, pp. S343-S351. https://doi.org/10.1093/infdis/jiaa668.